Skip to main content
. 2013 Nov 11;6(11):1429–1450. doi: 10.3390/ph6111429

Figure 10.

Figure 10

Genetic and Pharmacologic Inhibition of SMO downregulates mediators of stem cell pluripotency. (A) SMO siRNA downregulates expression of IPA human stem cell pluripotency pathway members as compared to non-targeting (NT) siRNA treated WM3248 and A375 cells. (B) NVP-LDE-225 downregulates expression of IPA human stem cell pluripotency pathway members as compared to DMSO- treated WM3248 and A375 cells.